Zeng S - Search Results

1

Photon-Driven Dye Induction Pyroptosis: An Emerging Anti-Tumor Immunotherapy Paradigm.

Zeng S, Wang J, Kang H, Li H, Peng X, Yoon J. Zeng S, et al. Angew Chem Int Ed Engl. 2025 Jan 10;64(2):e202417899. doi: 10.1002/anie.202417899. Epub 2024 Dec 2. Angew Chem Int Ed Engl. 2025. PMID: 39513509 Review.

2

Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.

Zhang L, Qian M, Cui H, Zeng S, Wang J, Chen Q. Zhang L, et al. Among authors: zeng s. ACS Appl Mater Interfaces. 2021 Feb 10;13(5):6053-6068. doi: 10.1021/acsami.0c21422. Epub 2021 Feb 1. ACS Appl Mater Interfaces. 2021. PMID: 33525873

3

Bioresorbable Depot for Sustained Release of Immunostimulatory Resiquimod in Suppressing Both Primary Triple-Negative Breast Tumors and Metastatic Occurrence.

Xie X, Wang J, Zhang L, Zeng S, Su X, Chen Q. Xie X, et al. Among authors: zeng s. Bioconjug Chem. 2021 May 19;32(5):1008-1016. doi: 10.1021/acs.bioconjchem.1c00171. Epub 2021 Apr 22. Bioconjug Chem. 2021. PMID: 33882675

4

Camptothecin Nanoprodrug Possessing Dual Responsiveness to Endolysosomal pH and Cytosolic Redox for Amplified Cytotoxic Potency.

Chen Q, Sui X, Zhang L, Zhang Q, Han X, Su X, Cui H, Qian M, Zeng S, Wang J. Chen Q, et al. Among authors: zeng s. ACS Appl Bio Mater. 2021 Jun 21;4(6):4990-4998. doi: 10.1021/acsabm.1c00272. Epub 2021 May 19. ACS Appl Bio Mater. 2021. PMID: 35007047

5

Reversible Chemical Protein Modification to Endogenous Glutathione and Its Utilities in the Manufacture of Transcellular Pro-Enzymes.

Wang Y, Zeng S, Cui H, Li H, Li Z, Wang J, Chen Q. Wang Y, et al. Among authors: zeng s. Biomacromolecules. 2022 May 9;23(5):2138-2149. doi: 10.1021/acs.biomac.2c00152. Epub 2022 Apr 26. Biomacromolecules. 2022. PMID: 35471918

6

Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma.

Cui H, Zhang L, Zeng S, Wang Y, Li Z, Wang J, Chen Q. Cui H, et al. Among authors: zeng s. ACS Appl Mater Interfaces. 2022 Jul 13;14(27):30493-30506. doi: 10.1021/acsami.2c03763. Epub 2022 Jun 3. ACS Appl Mater Interfaces. 2022. PMID: 35657733

7

Construction of Rhodamine-Based AIE Photosensitizer Hydrogel with Clinical Potential for Selective Ablation of Drug-Resistant Gram-Positive Bacteria In Vivo.

Zeng S, Wang Z, Chen C, Liu X, Wang Y, Chen Q, Wang J, Li H, Peng X, Yoon J. Zeng S, et al. Adv Healthc Mater. 2022 Sep;11(17):e2200837. doi: 10.1002/adhm.202200837. Epub 2022 Jul 1. Adv Healthc Mater. 2022. PMID: 35750469

8

Monitoring mitochondrial nitroreductase activity in tumors and a hind-limb model of ischemia in mice using a novel activatable NIR fluorescent probe.

Liu X, Zeng S, Zhang M, Jiang M, Kafuti YS, Shangguan P, Yu Y, Chen Q, Wang J, Peng X, Yoon J, Li H. Liu X, et al. Among authors: zeng s. Chem Commun (Camb). 2022 Oct 11;58(81):11438-11441. doi: 10.1039/d2cc04112j. Chem Commun (Camb). 2022. PMID: 36135099

9

Prospects of coupled iron-based nanostructures in preclinical antibacterial therapy.

Han J, Zeng S, Chen Y, Li H, Yoon J. Han J, et al. Among authors: zeng s. Adv Drug Deliv Rev. 2023 Feb;193:114672. doi: 10.1016/j.addr.2022.114672. Epub 2022 Dec 30. Adv Drug Deliv Rev. 2023. PMID: 36592895 Review.

10

Observing hydrogen sulfide in the endoplasmic reticulum of cancer cells and zebrafish by using an activity-based fluorescent probe.

Kafuti YS, Zeng S, Liu X, Han J, Qian M, Chen Q, Wang J, Peng X, Yoon J, Li H. Kafuti YS, et al. Among authors: zeng s. Chem Commun (Camb). 2023 Feb 23;59(17):2493-2496. doi: 10.1039/d2cc06645a. Chem Commun (Camb). 2023. PMID: 36752717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,721 results

Search Page

Filters